Search
01/11/2023
Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas
León, X, Bague, S, Holgado, A, Quer, M, Terra, X, Camacho, M, Aviltes-Jurado, FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.05.001. PMID:. IF:(Q/D).
01/11/2023
[[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.
Puig L. [[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.09.020. PMID:37778620. IF:(Q/D).
31/10/2023
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).
28/10/2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum
Goossens, J, González, AC, Dewit, N, Lidón, L, Fortea, J, Alcolea, D, Lleó, A, Belbin, O, Vanmechelen, E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:8.000(Q1/1D).
27/10/2023
Comparison of diluted vs concentrated regional citrate anticoagulation in continuous renal replacement therapy: A quasi-experimental study
Mateos-Dávila, A, Roig, AJB, Rodríguez, JAS, Guix-Comellas, EM. Comparison of diluted vs concentrated regional citrate anticoagulation in continuous renal replacement therapy: A quasi-experimental study. Nursing in Critical Care. 2023; DOI:10.1111/nicc.12991. PMID:37897131. IF:3.000(Q1/1D).
27/10/2023
Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine
Hueso, M, Rotllan, N, Escolà-Gil, JC, Vellido, A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:2.800(Q2/4D).
27/10/2023
Frontline therapy in Chronic Lymphocytic Leukemia
Arguello-Tomas, M, Albiol, N, Moreno, C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; 147(1)DOI:10.1159/000534730. PMID:37899041. IF:1.700(Q3/8D).
26/10/2023
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Kwatra, SG, Yosipovitch, G, Legat, FJ, Reich, A, Paul, C, Simon, D, Naldi, L, Lynde, C, De Bruin-Weller, MS, Nahm, WK, Sauder, M, Gharib, R, Barbarot, S, Szepietowski, JC, Conrad, C, Fleischer, A, Laquer, VT, Misery, L, Serra-Baldrich, E, Lapeere, H, Ahmad, F, Lopez, ZKJ, Piketty, C, Ständer, S. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(17)DOI:10.1056/NEJMoa2301333. PMID:37888917. IF:96.300(Q1/1D).